IIPLA News
Tuesday, June 9, 2026

Ingredion to Acquire Tate & Lyle for $5 Billion, Forming Global Specialty Ingredients Powerhouse

The $5 billion all-cash deal merges two leaders in specialty food ingredients, enhancing innovation and global reach across multiple regions

IIPLA News Deskanonymous access0 articles left this week
Ingredion to Acquire Tate & Lyle for $5 Billion, Forming Global Specialty Ingredients Powerhouse

Ingredion has unveiled plans to acquire Tate & Lyle in a recommended all-cash transaction valued at approximately £3.7 billion, equivalent to $5 billion. This strategic move is designed to establish a leading global provider of specialty ingredient solutions that emphasize healthier, tastier, and more sustainable food products.

The acquisition unites two companies with complementary expertise in areas including texturants, sugar reduction, mouthfeel, sweetening, fortification, and recipe development. Ingredion stated that the combination will strengthen its specialty ingredients platform and enhance its capacity to address shifting consumer preferences for nutritious, affordable, and high-quality food and beverages.

Geographically, the merger will integrate supply networks across the Americas, Europe, the Middle East and Africa, and Asia Pacific. This expanded footprint is expected to enable faster and more cost-effective delivery of ingredient solutions to customers on a global scale.

The transaction will also broaden formulation capabilities and accelerate innovation by combining the intellectual property, technology, and scientific expertise of both organizations.

Under the terms of the deal, Tate & Lyle shareholders will receive 595 pence per share, representing a premium of approximately 59% over the company’s closing share price on May 13, 2026. Ingredion anticipates generating annual run-rate net cost synergies of around $130 million, with full realization expected by the end of 2030.

The company projects the acquisition will be accretive to adjusted earnings per share in the first year following completion.

To finance the acquisition, Ingredion plans to utilize a combination of cash resources, new debt financing, and a committed bridge financing facility. Post-completion, the company expects net leverage to be approximately three times net debt-to-adjusted EBITDA, with plans to reduce leverage to about 2.5 times within 18 months.

The transaction is expected to close in the second half of 2027, contingent upon shareholder approvals, court sanction in the United Kingdom, and regulatory clearances.

Share This Article
Ready-to-post copy includes the article link.

Ingredion to Acquire Tate & Lyle for $5 Billion, Forming Global Specialty Ingredients Powerhouse Ingredion has announced a recommended acquisition of Tate & Lyle valued at approximately £3.7 billion ($5 billion). The transaction aims to create a scaled global provider of specialty ingredient solutions focused on he... Read the full IIPLA article: https://iipla.org/news/ingredion-to-acquire-tate-lyle-for-5-billion-forming-global-specialty-ingredients-powerhouse

Related Coverage

Continue in the newsroom

Back to newsroom
PatentsGlobal

Paul Weiss Expands Life Sciences Practice with Partner Ian Edvalson in San Francisco

Paul, Weiss, Rifkind, Wharton & Garrison has appointed Ian Edvalson as a partner in its San Francisco office, strengthening the firm’s life sciences transactions and intellectual property practices. Edvalson brings extensive experience advising biopharmaceutical and medical technology companies on licensing, collabora…

Friday, August 7, 2026
PatentsGlobal

Mexican Patent Law Overhaul Demands Early Strategic Planning from Applicants

In the first half of 2026, Mexico implemented sweeping patent reforms that significantly alter how patent applications are prepared, filed, and prosecuted. Key changes include a reduction in the number of substantive office actions and a mandated one-year examination timeline, compelling applicants to adopt earlier an…

Friday, August 7, 2026
PatentsGlobal

China Advances Comprehensive Pharmaceutical IP Protection with New Regulatory Frameworks

China’s pharmaceutical sector is rapidly evolving from generic manufacturing to innovative drug development, supported by a robust intellectual property protection system. Key measures including regulatory data protection, patent term extensions, patent linkage mechanisms, and strengthened judicial and administrative…

Friday, August 7, 2026
PatentsGlobal

T&G Global Posts Strong First-Half Results Driven by Premium Apple Sales

T&G Global reported a 2.6% revenue increase to $572.3 million for the six months ending June 30, 2024, led by a 6.1% rise in its Apples division revenue to $550.9 million. Operating profit grew 30% to $11.6 million before impairment adjustments related to the sale of T&G Fresh businesses. The company highlighted signi…

Friday, August 7, 2026